Increased nuchal translucency and cystic hygroma
Log in to starLast updated Nov 9, 2026
Nuchal translucency (NT) is the fluid-filled space under the skin at the back of the fetal neck, measured on a mid-sagittal view with the neck neutral, at 11 to 14 weeks. ACOG gives 10 0/7 to 13 6/7 weeks and a crown-rump length of about 45 mm (38 mm at some laboratories) to 84 mm. It is the ultrasound half of combined first-trimester screening. Undermeasuring by 0.5 mm cuts sensitivity by 18%.
Three cutoffs:
- 3.0 mm or more, or above the 99th centile for crown-rump length: ACOG's definition of enlarged. Some centers use 2.5 mm.
- Above the 95th centile: the lower cutoff in risk tables; it depends on crown-rump length.
- 3.5 mm or more (above the 99th centile): once aneuploidy is excluded, the risk of an adverse outcome starts to climb here, and it is the threshold for a fetal echocardiogram.
Cystic hygroma is the larger lymphatic form: a fluid-filled cavity at the back of the neck, often septated, that can extend down the length of the fetus. Sources put it above 5 to 6 mm, in either trimester.
- How big is it? The chance of a chromosome abnormality is about 7% from the 95th centile to 3.4 mm, 20% at 3.5 to 4.4 mm, 45% at 4.5 to 5.4 mm, 50% at 5.5 to 6.4 mm, and 70% to 75% at 6.5 mm and above. The mix shifts with size: trisomy 21 is two thirds of the abnormal results at the low end, while 45,X rises to 70% of them above 11.5 mm.
- Are the chromosomes normal? Karyotype and microarray first; the single-gene differential opens after.
- What does the 18 to 22 week scan show? A resolved NT with normal anatomy and a normal heart is the reassurance.
Other first-trimester markers travel with NT: absent nasal bone, tricuspid regurgitation, and a reversed a-wave in the ductus venosus. The reversed a-wave is seen in about two thirds of fetuses with trisomy 21 and 3% of euploid fetuses, and it also raises the chance of a heart defect.
Chromosome abnormalities
- Trisomy 21: the most common abnormality at all but the largest measurements, and the leading aneuploidy with a first-trimester cystic hygroma.
- Trisomy 18 and trisomy 13: NT is rarely the only finding. Look for early growth restriction, heart defects, and holoprosencephaly in trisomy 13.
- Turner syndrome (45,X): cystic hygroma is the hallmark, more often in the second trimester, with nonimmune hydrops, coarctation, and horseshoe kidney.
- Triploidy, plus unbalanced translocations, marker chromosomes, mosaicism, and copy number variants.
Normal chromosomes: the heart
- Congenital heart disease: a major defect in about 6% (range 3% to 12%) of euploid fetuses with NT 3.5 mm or more.
Normal chromosomes: RASopathies
- Noonan syndrome: autosomal dominant, often de novo; PTPN11 in about half, also SOS1, RAF1, RIT1, KRAS. About 15% of euploid fetuses with a large NT and 9% to 17% of euploid cystic hygromas. Polyhydramnios may accompany the NT; pulmonary stenosis and hypertrophic cardiomyopathy are the usual heart findings.
- Cardiofaciocutaneous syndrome and the other RASopathies: CFC brings fetal edema and polyhydramnios (BRAF, MAP2K1, MAP2K2, KRAS).
Normal chromosomes: other causes
- Skeletal dysplasias.
- Multiple pterygium syndrome.
- Abdominal wall defects, diaphragmatic hernia, congenital infection, and metabolic and hematologic disorders.
- "Septated cystic hygroma on the second-trimester scan" is 45,X until proven otherwise. In the first trimester, trisomy 21 leads.
- "Increased NT, normal microarray, then pulmonary stenosis or polyhydramnios" is Noonan syndrome. Examine both parents: the adult face is subtler, and about half of cases have a family history.
- A shrinking NT has not excluded aneuploidy. Nuchal edema can resolve in a chromosomally abnormal fetus, and hygromas regress in about 10% of aneuploid cases.
- One enlarged NT in a size-discordant monochorionic twin pair can be early twin-twin transfusion syndrome rather than aneuploidy.
- NT versus nuchal fold. The nuchal fold is a second-trimester soft-tissue measurement, 6 mm or more from the outer occipital bone to the outer skin, and belongs with the second-trimester soft markers.
- Genetic counseling and diagnostic testing: CVS or amniocentesis. A low-risk cell-free DNA result does not close the question: the differential includes copy number variants and single-gene disorders.
- Karyotype and chromosomal microarray. Microarray finds a significant variant in about 6% of fetuses with a structural finding and a normal karyotype.
- Detailed anatomy scan at 18 to 22 weeks and a fetal echocardiogram (offered for any enlarged NT with normal chromosomes, recommended at 3.5 mm or more).
- RASopathy panel when the microarray is normal, then exome, ideally as a trio (8% to 10% yield after a normal karyotype and microarray).
- Size drives everything. Among euploid fetuses, a live birth without defects falls from 92% at the 95th centile to 3.4 mm to 20% at 6.5 mm or more.
- Normal chromosomes, a resolved NT, and a normal detailed scan and heart: better than a 95% chance of no major abnormality. One large follow-up found a sixfold relative rise in intellectual disability above the 99th centile, under 1% absolute.
- Cystic hygroma is 50% to 70% aneuploid and carries a worse prognosis than increased NT even with normal chromosomes, though 89% of euploid hygromas without other anomalies or hydrops were normal at follow-up in one series.